The problem with their ML strategy is that it consistently over-promises and under-delivers. The marketing and messaging doesn't trail the research; the researc

The problem with their ML strategy is that it consistently over-promises and under-delivers. The marketing and messaging doesn't trail the research; the research is driven by the corporate messaging by half a decade or more. It's completely backwards, and that's just the start, but it's what you should expect from a corporation paralysed by risk aversion. Some of the insider postmortems on Watson Health that are floating around on the internet are... interesting.